Literature DB >> 3396261

Maturation of caffeine metabolic pathways in infancy.

O Carrier1, G Pons, E Rey, M O Richard, C Moran, J Badoual, G Olive.   

Abstract

The maturation of the different pathways of caffeine metabolism was studied during infancy. The group of children (n = 14) consisted of four premature newborn infants and 10 older infants who received caffeine citrate solution. Caffeine and 11 of its metabolites were measured by HPLC. Total demethylation and N3- and N7-demethylation increase exponentially with postnatal age; the plateau is reached by 120 days and accounts for 58.6%, 90.5%, and 79.3%, respectively. N1-demethylation shows no variation with postnatal age. It is suggested that N3-demethylation is more important in young infants than in adults and that maturation of N1-demethylation occurs later than 19 months of age. 8-Hydroxylation is mature as early as 1 month of age and may be higher in infants than in adults. Acetylation is not mature before at least 1 year of age. Differences in maturation rate of acetylation may be related in part to genetic acetylator status.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396261     DOI: 10.1038/clpt.1988.129

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

1.  Excretion of fluvoxamine into breast milk.

Authors:  S Hägg; K Granberg; L Carleborg
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

2.  Sequential updating of a new dynamic pharmacokinetic model for caffeine in premature neonates.

Authors:  Sandrine Micallef; Billy Amzal; Véronique Bach; Karen Chardon; Pierre Tourneux; Frédéric Y Bois
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  The perinatal effects of maternal caffeine intake on fetal and neonatal brain levels of testosterone, estradiol, and dihydrotestosterone in rats.

Authors:  S Karaismailoglu; M Tuncer; S Bayrak; G Erdogan; E L Ergun; A Erdem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-29       Impact factor: 3.000

Review 4.  Treatment of apnea of prematurity.

Authors:  Varsha Bhatt-Mehta; Robert E Schumacher
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 5.  Developmental pharmacokinetics in pediatric populations.

Authors:  Hong Lu; Sara Rosenbaum
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

6.  Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.

Authors:  C Cazeneuve; G Pons; E Rey; J M Treluyer; T Cresteil; G Thiroux; P D'Athis; G Olive
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

7.  Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test.

Authors:  A C Parker; T Preston; D Heaf; N R Kitteringham; I Choonara
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

8.  Effect of pregnandiol on caffeine metabolism in female rats.

Authors:  T Bienvenu; G Pons; E Rey; G Thiroux; G Olive
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Apr-Jun       Impact factor: 2.441

Review 9.  Caffeine citrate: a review of its use in apnoea of prematurity.

Authors:  A M Comer; C M Perry; D P Figgitt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

Review 10.  Ontogeny of Drug-Metabolizing Enzymes.

Authors:  Aarzoo Thakur; Md Masud Parvez; J Steven Leeder; Bhagwat Prasad
Journal:  Methods Mol Biol       Date:  2021
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.